Quick Takeaways
- Iliad Research & Trading, L.P. filed SCHEDULE 13G for Jaguar Health, Inc. Common Stock, Par Value $0.0001 Per Share (JAGX).
- Disclosed ownership: 9.8%.
- Date of event: 11 Dec 2025.
Iliad Research & Trading, L.P. - 11 Dec 2025 SCHEDULE 13G Report for Jaguar Health, Inc. Common Stock, Par Value $0.0001 Per Share (JAGX)
- Filing Manager
- Iliad Research & Trading, L.P.
- Reporting Manager
- Iliad Research & Trading, L.P.
- Symbol
- JAGX
- Shares outstanding
- 4,489,796 shares
- Disclosed Ownership
- 440,000 shares
- Ownership
- 9.8%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Dec 2025, 16:49:34 UTC
- Date of event
- 11 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iliad Research & Trading, L.P. disclosed 9.8% ownership in Jaguar Health, Inc. Common Stock, Par Value $0.0001 Per Share (JAGX) on 11 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Dec 2025, 16:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iliad Research & Trading, L.P. | 9.8% | 440,000 | 440,000 | 0 | John Fife | President | |
| Iliad Management, LLC | 9.8% | 440,000 | 440,000 | 0 | John Fife | President | |
| Fife Trading, Inc. | 9.8% | 440,000 | 440,000 | 0 | John Fife | President | |
| John M. Fife | 9.8% | 440,000 | 440,000 | 0 | John Fife | John Fife |